Picture

Northwestern Medicine
​Breakthroughs for Physicians

​​
  • Home
  • Specialties
    • Cardiovascular >
      • Research
      • Clinical Breakthroughs
      • News
    • Endocrinology >
      • Clinical Breakthroughs In Endocrinology
      • Research In Endocrinology
      • News
    • ENT (Otolaryngology) >
      • Clinical Breakthroughs
      • Research
      • News
    • Gastroenterology >
      • Clinical Breakthroughs
      • Research
      • News
    • Geriatrics >
      • Clinical Breakthroughs
      • Research
      • News
    • Neurosciences >
      • Rare and Complex Brain Tumors
      • Research
      • COVID-19 and Neurosciences
      • News
      • Clinical Breakthroughs
    • OB-GYN >
      • Clinical Breakthroughs
      • Research
      • News
    • Oncology >
      • Clinical Breakthroughs
      • Research
      • News
    • Ophthalmology >
      • Clinical Breakthroughs
      • Research
      • News
    • Organ Transplant >
      • Clinical Breakthroughs
      • Research
      • News
    • Orthopaedics >
      • Clinical Breakthroughs
      • Research
      • News
    • Psychiatry >
      • Clinical Breakthroughs
      • Research
      • News
    • Pulmonary >
      • Clinical Breakthroughs
      • Research
      • News
    • Rehabilitation >
      • Clinical Breakthroughs
      • News
    • Rheumatology >
      • Clinical Breakthroughs
      • Research
      • News
    • Urology >
      • Clinical Breakthroughs
      • Research
      • News
  • CME
  • REFERRALS
    • Refer to NM Cardiovascular
    • Refer to NM Neurosciences
    • Refer to Other Specialties

< BACK TO ONCOLOGY

Picture

lURIE CANCER CENTER AND Northwestern Medicine
​EXPERTS TO PRESENT AT ASCO 2023

Physicians and scientists from the Robert H. Lurie Comprehensive Cancer Center of Northwestern University and Northwestern Medicine will present and discuss leading-edge research in cancer care at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting, June 2-6 at McCormick Place in Chicago, and Online. Visit us at Booth 3026. 
 
The program features more than 200 sessions complementing the meeting’s theme: Partnering with Patients - The Cornerstone of Cancer Care and Research. 

During ASCO’s Plenary Session, Rimas V. Lukas, MD, will discuss a practice-changing neuro-oncology study (Discussion of LBA1) and share implications for future research. Presentations in this special session on Sunday, June 4, showcase scientific research deemed to have the greatest impact on oncology research and treatment. Visit us at Booth 3026.


​Congratulations to 
Anthony Serritella, MD, on receiving a Young Investigator Award from ASCO’s Conquer Cancer Foundation, to be presented in conjunction with #ASCO23.
read about his mentored clinical research
See all award recipients


​Use #ASCO23 to follow and share insights from the meeting on Twitter, tagging:
  • Lurie Cancer Center: @LurieCancer
  • Northwestern Medicine: @NorthwesternMed
 
Lurie Cancer Center investigators who are leading sessions and presenting pivotal research findings, include*:

Date & Time
Session
Presenter
*Discussant
Learn More

Saturday, June 3
8:00 AM 
Genitourinary Cancer – Kidney and Bladder
Health-related quality of life (HRQoL) of risk-based patient subgroups with advanced renal cell cancer (aRCC) treated with nivolumab plus cabozantinib (NIVO+CABO) vs sunitinib (SUN) in the CheckMate 9ER trial. ​Abstract: 4527
David Cella, PhD
VIEW DETAILS

Case-Based Panel 
Optimizing Brain Metastases Treatments to Minimize and Manage Neurologic Toxicities 
​The Radiation Oncologist Perspective
Vinai Gondi, MD
View details

Developmental Therapeutics – Molecularly Targeted Agents & Tumor Biology
Systematic review and meta-analysis of the accuracy and applicability of blood-based multi-cancer early detection (MCED) in the general population. Abstract: 3069
Joo Hee Park, MD
VIEW DETAILS

Developmental Therapeutics – Immunotherapy
Use of proteomimetic polymers for delivery of tumor antigens and adjuvants through formation of stable electrostatic complexes with small molecule STING agonists. Abstract: 2583
Max Mu Wang, MPH ​
view details

​Genitourinary Cancer—Prostate, Testicular, and Penile
Longitudinal transcriptome profiling of localized hormone-sensitive tumors in treatment-naïve ENACT patients with prostate cancer with and without enzalutamide (ENZA). Abstract: 5026
Ashley E. Ross, MD, PhD
View Details

1:15 PM

Health Services Research and Quality Improvement 
Disparities in intensity of care at the end-of-life for patients with gastrointestinal cancer. Abstract: 6658
Evaluation of cachexia and outcomes in patients with aggressive B-cell non-Hodgkin lymphoma. Abstract: 6624
Gladys M. Rodriguez, MD
Nicholas Demetriou, BSc
VIEW DETAILS

Prevention, Risk Reduction, and Hereditary Cancer 
Metformin for chemoprevention of lung cancer in high-risk overweight or obese individuals. Abstract: TPS10636
Isra Nour, MBBS
VIEW DETAILS

Central Nervous System Tumors
Vulnerability to immune therapy in BRAF- and MYB-altered pediatric gliomas. Abstract: 2066
Michael DeCuypere, MD, PhD
view details

4:30 PM
Sarcoma
A phase II basket trial of dual anti–CTLA-4 and anti–PD-1 blockade in rare tumors (DART) SWOG S1609: The desmoid tumors (cohort 27). Abstract: 11516
Young Kwang Chae, MD, MPH
view details

Sunday,
June 4


8:00 AM
Breast Cancer Metastatic  
Multi-factor dynamic analysis of ctDNA and CTC to aid the diagnostic prognosis of patients with metastatic breast cancer (MBC). Abstract: 1038
Qiang Zhang, MD, PhD
view details

Genitourinary Cancer – Prostate, Testicular, and Penile 
DDR and PARP Inhibition: What's the Damage?
Abstract Discussion 2

David VanderWeele, MD, PhD*
View Details

11:30 AM
Breast Cancer Metastatic  
​HER2-low status discordance between primary and recurrent/metastatic breast cancer in a large-scale cohort. Abstract: 1021
Hui Zhang, PhD
view details

1:00 PM
Plenary Session – Special Sessions 
Abstract presentations in this session showcase scientific research deemed to have the highest merit and greatest impact on oncology research and practice. Experts in the field serve as discussants placing clinical research findings into perspective and sharing implications for future research.
Discussion of LBA1, a practice-changing study of the novel brain-penetrant IDH1 inhibitor (vorasidenib) for the treatment of IDH-mutated glioma, a primary brain tumor that often affects young patients in the third or fourth decade of life.
Rimas Lukas, MD*
view details

4:30 PM
Breast Cancer – Local/Regional/Adjuvant
Breast Cancer Surgery: Too Much, Too Little, Just Right
Abstract Discussion 4

Seema Khan, MD*
View Details

Monday, June 5

8:00 AM
Hematologic Malignancies – Lymphoma & Chronic Lymphocytic Lymphoma
Impact of neighborhood deprivation on disability free survival in patients with aggressive B cell non-Hodgkin lymphoma. Abstract: 7564
Madelyn Burkart, MD
​
view details

Gastrointestinal Cancer – Gastroesophageal, Pancreatic and Hepatobiliary 
Alliance A021806: A phase III trial evaluating perioperative versus adjuvant therapy for resectable pancreatic cancer.
Abstract: TPS4204

Akhil Chawla, MD
View Details

4:30 PM
Gynecologic Cancer
A phase II basket trial of dual anti–CTLA-4 and anti–PD-1 blockade in rare tumors (DART) SWOG S1609: The vulvar cancers. Abstract: 5517
Young Kwang Chae, MD, MPH
view details

Tuesday, June 6

12:45 PM
Hematologic Malignancies – Lymphoma and Chronic Lymphocytic Lymphoma
​Striking a Balance with Immunotherapy in Non-Hodgkin Lymphoma. Abstract Discussion 3
Reem Karmali, MD*
view details

Publication Only

Head and Neck Cancer
Retrospective analysis of NUT carcinoma: The Northwestern experience. Abstract e18096
First Author: Anthony Serritella, MD
View Abstract

​NORTHWESTERN MEDICINE onCOLOGY

The Robert H. Lurie Comprehensive Cancer Center of Northwestern University at Northwestern Memorial Hospital is a global leader in a broad range of cancer types thanks to its dedication to comprehensive research, world-renowned faculty and staff and its commitment to making ongoing advances in medical, surgical, radiation and interventional oncology. The Lurie Cancer Center is designated by the National Cancer Institute as one of only 53 comprehensive cancer centers in the nation recognized  for their scientific leadership, resources and the depth and breadth of their research. In addition, Lurie Cancer Center is a founding member of the National Comprehensive Cancer Network (NCCN) and our physicians actively participate in writing NCCN patient guidelines for each type cancer.
BREAKTHROUGHS
RESEARCH
COVID-19

Find a Lurie Cancer Center Physician Expert

Northwestern Medicine welcomes the opportunity to partner with you in caring for your patients.

Find an Oncologist

follow northwestern medicine oncology

NM Oncology on Twitter
NM Oncology Video Channel
NM Better Edge Podcast

Northwestern Medicine Breakthroughs for Physicians

About Us     Terms of Use     Privacy Policy     How to Vote for U.S. News & World Report Best Hospitals
© 2025 Northwestern Medicine® and Northwestern Memorial HealthCare. 
Northwestern Medicine® is a trademark of Northwestern Memorial HealthCare, used by Northwestern University
Connect with us
[email protected]
International physicians, contact [email protected]
  • Home
  • Specialties
    • Cardiovascular >
      • Research
      • Clinical Breakthroughs
      • News
    • Endocrinology >
      • Clinical Breakthroughs In Endocrinology
      • Research In Endocrinology
      • News
    • ENT (Otolaryngology) >
      • Clinical Breakthroughs
      • Research
      • News
    • Gastroenterology >
      • Clinical Breakthroughs
      • Research
      • News
    • Geriatrics >
      • Clinical Breakthroughs
      • Research
      • News
    • Neurosciences >
      • Rare and Complex Brain Tumors
      • Research
      • COVID-19 and Neurosciences
      • News
      • Clinical Breakthroughs
    • OB-GYN >
      • Clinical Breakthroughs
      • Research
      • News
    • Oncology >
      • Clinical Breakthroughs
      • Research
      • News
    • Ophthalmology >
      • Clinical Breakthroughs
      • Research
      • News
    • Organ Transplant >
      • Clinical Breakthroughs
      • Research
      • News
    • Orthopaedics >
      • Clinical Breakthroughs
      • Research
      • News
    • Psychiatry >
      • Clinical Breakthroughs
      • Research
      • News
    • Pulmonary >
      • Clinical Breakthroughs
      • Research
      • News
    • Rehabilitation >
      • Clinical Breakthroughs
      • News
    • Rheumatology >
      • Clinical Breakthroughs
      • Research
      • News
    • Urology >
      • Clinical Breakthroughs
      • Research
      • News
  • CME
  • REFERRALS
    • Refer to NM Cardiovascular
    • Refer to NM Neurosciences
    • Refer to Other Specialties